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Abstract
Meta-analyses are an essential tool of clinical research. Meta-analyses of individual randomized
controlled trials frequently constitute the highest possible level of scientific evidence for a given
research question and allow surgeons to rapidly gain a comprehensive understanding of an
important clinical issue. Moreover, meta-analyses often serve as cornerstones for evidence-based
surgery, treatment guidelines, and knowledge transfer. Given the importance of meta-analyses to
the medical (and surgical) knowledge base, it is of cardinal importance that surgeons have a basic
grasp of the principles that guide a high-quality meta-analysis, and be able to weigh objectively the
advantages and potential pitfalls of this clinical research tool. Unfortunately, surgeons are often ill-
prepared to successfully conduct, critically appraise, and correctly interpret meta-analyses. The
objective of this educational review is to provide surgeons with a brief introductory overview of
the knowledge and skills required for understanding and critically appraising surgical meta-analyses
as well as assessing their implications for their own surgical practice.
Background
The statistical tool of meta-analysis is used with increasing
frequency in surgical research. A recent review demon-
strates that over the past decade, appearances of meta-
analyses in the medical literature have increased by four-
fold [1]. The vast majority of meta-analyses combine
results from different randomized controlled trials (RCTs)
and, to a much lesser extent, cohort studies or case-control
studies. In the interest of brevity, we will focus this short
educational review on meta-analyses of RCTs only.
Since their invention and subsequent application in the
medical literature in the early 20th century [2], meta-anal-
yses have continuously evolved. The practice of perform-
ing high-quality, methodologically sound, and critically
evaluated meta-analyses culminated in the creation of the
Cochrane Group. Named for Archie Cochrane, a British
researcher who contributed greatly to the development of
modern epidemiology, the Cochrane group was estab-
lished 15 years ago and is an international collaboration
of over 10,000 investigators who appraise and compile
high-quality meta-analyses on numerous topics, with over
1,600 published to date [3].
Given the ubiquity of meta-analyses in the current flour-
ishing culture of evidence-based medicine, it is imperative
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for the practicing surgeon to acquire a basic understand-
ing of the advantages and limitations of meta-analyses.
Unfortunately, many surgeons lack a solid foundation in
this essential area of knowledge. The present article repre-
sents an invited review and is based on different educa-
tional articles by the senior author (U.G.) [4-9]. Our
objective is to provide a brief introductory overview of the
techniques used to perform a meta-analysis and discuss
some of the advantages and potential shortcomings of
this statistical tool.
Basic Statistical Background
If we are to understand and successfully apply the tool of
meta-analysis, we must first briefly review some impor-
tant statistical concepts, which have been described in
greater detail by the senior author [6-8]. In statistical
terms, there are two basic ways study findings can err.
First, the study results might lead to an erroneous conclu-
sion that a statistically significant difference exists
between study groups when in reality it does not (Table 1,
cell B). The second form of error is the reverse of the first:
the study results might lead to an erroneous conclusion
that there is no significant difference between the study
groups when in reality a difference does exist (Table 1, cell
C).
The first situation represents false-positive result and is
called a type I error. The bound that we put on the proba-
bility of committing a type I error is named alpha, also
referred to as the level of statistical significance or significance
level. The second situation represents a false-negative
result and is called a type II error or beta error. Beta, the
false-negative rate, is complementary to the power of a
study [6], which is defined as the probability of finding a
statistically significant result (i.e., rejecting the null
hypothesis) in a study when a true difference exists
between or among the groups of subjects being compared.
Often in biomedical research alpha is set at 0.05, meaning
that a 5% chance of obtaining a false-positive result (i.e.,
the results show a statistically significant difference even
though no real difference exists) is considered acceptable.
Alpha is the benchmark to which p values are compared.
If the p value is larger than alpha, a result is said to be non-
significant. On the other hand, if the p value is smaller
than the benchmark alpha, the findings are considered
statistically significant.
Although it might at first seem reasonable to assume that
both alpha and beta errors could be set at the same level
of 5%, a false-positive finding is often considered poten-
tially more harmful than a false-negative result (e.g., find-
ing a surgical procedure to be beneficial to patients when
no benefit actually exists). Thus, in medical science, beta
is commonly set between 0.2 and 0.1. As the power of a
study is complementary to the beta error, type II errors of
0.2, 0.15, and 0.1 correspond to statistical powers of 80%
(1.0-0.2), 85% (1.0-0.15), and 90% (1-0.10), respec-
tively.
It is important to recall that the sample size of a study is
directly proportional to the power: the larger the sample
size, the higher the power. This simple statistical concept
is of tremendous importance to meta-analyses. A meta-
analysis combines different RCTs to increase the overall
sample size, thus increasing the statistical power. This
increase in statistical power in turn shrinks the value of
beta, with result that the chances of a false-negative find-
ing are minimized in a well-performed meta-analysis.
Finally, effect size forms a critical part of evaluating meta-
analyses, as has been described by the senior author in
greater detail elsewhere [9]. In summary, a meta-analysis
combines the results of multiple studies that test a similar
research hypothesis. Thererfore, the findings of individual
RCTs (effect sizes) are combined using statistical tech-
niques into an overall effect size, sometimes called meta-
effect size. The meta-effect size is a more powerful and
accurate estimate of the true effect sized compared with
individual single studies.
Steps in Performing a Meta-Analysis
A thorough understanding and appreciation of all of the
steps in the process of performing a meta-analysis is essen-
tial for the reader. This importance is reflected in an
admonition contained within the Cochrane Handbook:
eager clinical trialists seeking to skip steps on the way to
performing the statistical calculations for a meta-analysis
are greeted with the warning: "Don't start here!" [10]. The
different steps [11,12] include:
Table 1: Type I (alpha) and type II (beta) error [6].
Truth in the overall patient population
Treatment difference No treatment difference
Study results Treatment difference A. Correct conclusion B. Type I error (false-positive result)
No treatment difference C. Type II error (false-negative result) D. Correct conclusionPatient Safety in Surgery 2009, 3:16 http://www.pssjournal.com/content/3/1/16
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1. Formulate a research question.
2. State the a priori hypothesis (a hypothesis gener-
ated prior to collecting the data). This step is vital to
ensuring the validity of the meta-analysis. No matter
how tempting it might be to form hypotheses as inter-
esting correlations or patterns appear in the collected
data, doing so is likely to bias the meta-analyses irre-
trievably and diminish its validity.
3. Write a protocol in which the research question, as
well as inclusion and exclusion criteria for the trials to
be pooled in the meta-analysis, are clearly described.
4. Perform a thorough literature search using several
different search engines (e.g., PubMed, Embase,
Cochrane, Google Scholar, etc.). Be sure to formally
document the search strategies used and the results
that the searches retrieved; the sensitivity and preci-
sion of the literature search is itself likely to affect the
ultimate validity of the findings [13-16]. A non-elec-
tronic hand searching of the literature may also be use-
ful, despite the time and effort required [17].
5. Perform a quality assessment (critical appraisal)
and extraction of studies (usually performed by two
independent investigators).
6. Extract the data from the RCTs.
7. Perform a statistical analysis (including a sensitiv-
ity analysis).
8. State conclusions and provide recommendations.
Researchers may also wish to consult the guidelines estab-
lished by the Quality of Reporting of Meta-Analyses
(QUOROM) group [18]. The QUORUM guidelines, much
like the CONSORT guidelines for reporting RCTs in the
peer-reviewed literature [19], contain a listing of essential
steps and items that must be included in a well-conducted
meta-analysis. The QUOROM guidelines also incorporate
flowcharts and checklists to be used when drafting a
report on a meta-analytical study (Figure 1).
As we examine in detail the steps of performing a meta-
analysis, it is important to emphasize particular aspects of
the process. First, as with any study, the value of a meta-
analysis can be assessed using the mnemonic 'FINER'.
That is, the study must be Feasible, Interesting, Novel,
Ethical, and Relevant [20]. If a meta-analysis is feasible
and ethical but not relevant and novel, it will be worth-
less–there is little to be gained from answering questions
without any clinical relevance, or re-hashing research
questions that have been thoroughly and definitively
addressed.
Second, the literature search for relevant RCTs should be
undertaken only after a protocol has been written, with a
priori  hypotheses and inclusion and exclusion criteria
clearly defined. Ideally, at least two independent investi-
gators should search for studies that meet inclusion crite-
ria. Further, the search should be as comprehensive as
possible; that is, not limited only to Medline, but rather
spread among other scientific databases (e.g., Embase,
Cochrane, Google Scholar, etc.) to minimize the possibil-
ity of omitting a study of interest simply because of the
vagaries of data collection or indexing. Similarly, limits on
the language of the publication, date, country of origin,
etc. should be avoided if possible. Moreover, as explained
in greater detail below, performing a systematic search for
unpublished studies is imperative.
Finally, two independent investigators must assess the
quality and suitability of retrieved studies. Assessments
and decisions regarding inclusion of a given study in the
meta-analysis should be based on the inclusion and exclu-
sion criteria outlined in the protocol.
Hypothetical flow chart based on the QUOROM statement Figure 1
Hypothetical flow chart based on the QUOROM 
statement. This diagram represents a hypothetical flow 
chart based on the QUOROM statement flow diagram 
(modified from that provided by the Cochrane collaboration, 
http://www.cochrane.org). The object of such diagrams is to 
improve the quality of reports of meta-analyses of rand-
omized controlled trials (RCT).Patient Safety in Surgery 2009, 3:16 http://www.pssjournal.com/content/3/1/16
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Interpretation of Forest Plots
In a meta-analysis, the combined data from the various
selected RCTs are typically presented as forest plots (Fig-
ure 2) [21]. Correct interpretation of these forest plots is
crucial for the surgical reader and deserves some discus-
sion. Forest plots use boxes and "whiskers" (horizontal
lines indicating the spread of the 95% confidence inter-
val) to represent individual trials. On close inspection, the
reader will note that the size of the boxes varies among the
different studies represented. In fact, box size correlates
directly with the sample size (number of patients
enrolled) of an RCT. For instance, in Figure 2, Study 5 has
a larger sample size (larger box) compared with Studies 7
and 8. Such larger trials will carry more weight in the
meta-analysis than smaller trials.
As mentioned above, the whiskers represent the 95% con-
fidence intervals. These 95% confidence intervals com-
prise the range of values for which you can be 95%
confident that the true value is included, and help provide
the reader with an appreciation of the reliability of the
results. The wider the 95% confidence intervals, the
higher the uncertainty that the reported results are accu-
rate [7]. The width of the 95% confidence intervals is indi-
rectly proportional to the sample size of the RCT: if the
trial includes a large number of patients (e.g., Study 5, Fig-
ure 2), the width of the 95% confidence intervals will be
narrow; as sample sizes dwindle, the 95% confidence
intervals correspondingly grows wider.
In addition to providing information on the reliability of
the results, the whiskers of a 95% confidence interval can
inform the reader as to whether the study was statistically
significant [7]. If the confidence interval crosses the verti-
cal line of no effect (0 for a difference between two groups
and 1 for a ratio of two groups), then that trial result,
taken individually, is not  statistically significant (e.g.,
Study 6 in Figure 2). Conversely, if the confidence interval
does not cross the vertical line of no effect, the result is sta-
tistically significant (e.g., Studies 5 and 8 in Figure 2). The
overall result (summary effect) is represented by the dia-
mond shape. In Figure 2, the confidence interval does not
cross the line of no effect and thus represents a statistically
significant overall result (p < 0.05).
Advantages of Meta-Analysis
When performed properly, meta-analyses have a number
of important advantages over individual RCTs. These
include:
Increasing power
The primary advantage of meta-analyses is an increase in
statistical power over that of individual RCTs. As previ-
ously mentioned, power is defined as the probability of
detecting a statistically significant result if the patient sam-
ples are truly different [7,9]. For various reasons that are
often difficult to predict beforehand, RCTs frequently
prove to be underpowered. In other words, they enroll too
few patients to prove that a detected difference, even when
clinically relevant, is statistically significant [7,22]. The
result is a negative study; in other words, the p  value
exceeds the threshold for significance. In these small RCTs
A simplified, hypothetical example of a forest (meta-analysis)  plot Figure 2
A simplified, hypothetical example of a forest (meta-
analysis) plot. This figure represents a simplified, hypothet-
ical example of a forest (meta-analysis) plot demonstrating 
eight RCTs comparing laparoscopic versus open appendec-
tomy with respect to postoperative wound infections. Each 
RCT is represented by a square (the odds ratio found for this 
trial) and a horizontal line, which represents the 95% confi-
dence interval. If the square is to the left of the vertical line 
of no effect (odds ratio = 1, e.g. studies 1, 2, 3, 5, 6, and 8), 
the study favors laparoscopic appendectomy; if the square is 
to the right of the line (e. g. studies 4 and 7), then open 
appendectomy is favored. If the 95% confidence interval 
crosses the line of no difference (odds ratio = 1), then the 
trial is not statistically significant (e.g., studies 1, 2, 3, and 6). 
Conversely, if the 95% confidence interval does not cross the 
line of no effect (odds ratio = 1), then this trial yields a statis-
tically significant difference. Studies 4 and 7 found a significant 
advantage in favor of open appendectomy, whereas studies 5 
and 8 found significantly less wound infection in the group 
randomized to laparoscopic appendectomy, indicating con-
siderable heterogeneity. The size of the squares varies with 
respect to the sample size of each individual trial: the larger 
the sample size, the larger the square will be. An overall 
(pooled) effect is represented by the diamond. In this case, 
the overall results demonstrate a statistically significant 
reduction of postoperative wound infections in the group 
randomized to laparoscopic appendectomy (Forest plot cre-
ated with StatsDirect v. 2.7.2; StatsDirect Ltd., Cheshire, 
UK).Patient Safety in Surgery 2009, 3:16 http://www.pssjournal.com/content/3/1/16
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it may be unclear whether the lack of statistical signifi-
cance truly reflects the fact that there is no difference
between treatments, or whether the sample size was sim-
ply too small to demonstrate that a detected difference
was significant. As mentioned earlier, meta-analyses may
overcome this limitation by combining different RCTs,
thereby increasing overall sample size (and with it, statis-
tical power) in a way that would simply not be feasible if
one were to attempt creating a single RCT with a compa-
rable sample size.
Providing a unifying conclusion
Often, in a given area of interest, various RCTs may pro-
vide contradictory results. Quite commonly, this occurs
for the same reason discussed above: the sample sizes for
the various RCTs were not sufficient to ensure a definitive
answer to the research question. This confusion, however,
can be abated by applying the tool of meta-analysis,
which can reveal an underlying unifying conclusion
among seemingly contradictory study findings.
For a practical example, let us consider the role of neoad-
juvant chemotherapy prior to radical cystectomy with
extended lymphadenectomy in the treatment of bladder
cancer. There have been many conflicting RCTs performed
in this clinical arena, some of which found a statistically
significant overall survival advantage with neoadjuvant
chemotherapy in addition to radical cystectomy, while
others found no such advantage. In order to elucidate this
issue, a meta-analysis combining the various RCTs was
performed. The meta-analysis demonstrated a 5% abso-
lute improvement in overall survival at 5 years when more
than 3000 patients from 11 RCTs were analysed [22]. In
this case, a meta-analysis helped reveal a unifying conclu-
sion and led to important gains in knowledge as well as
direct benefit for patients.
Limitations of Meta-Analyses
When conducted with appropriate statistical techniques
and with high-quality data, findings from meta-analyses
are considered to be the highest level of evidence (level 1a
evidence) [23]. However, as the saying goes, "the devil is
in the details." Despite their widespread acceptance, some
authorities have remained skeptical about the overall use-
fulness and reliability of meta-analyses; moreover, the
techniques used in a meta-analysis are quite sensitive to
the care and skill of the persons performing the analysis.
For this reason, the surgical reader should bear in mind a
number of important caveats (summarized in Table 2).
Garbage in-garbage out phenomenon
It is quite possible for a researcher to apply methodologi-
cally sound meta-analytical techniques to suboptimal
data. Unfortunately no amount of statistical technique
can improve the fundamental quality of the data being
combined for the meta-analysis. If the individual RCTs
that make up the meta-analysis are themselves poorly
designed and poorly conducted, the meta-analysis sum-
marizing these trials will be of correspondingly limited
reliability. Remember: garbage in-garbage out [8]!
It is important to acknowledge that RCTs in surgery are
themselves subject to their own particular challenges and
sets of biases as has been discussed previously by the sen-
ior author in greater detail elsewhere [4,5]. Briefly, typical
caveats of surgical trials include limitations such as low
external validity (poor generalizability), difficulty of
blinding patients and investigators, co-intervention bias,
lost-to-follow-up bias, and performance bias. Because it is
often difficult to control for these biases it is therefore
important that the astute reader of a meta-analysis evalu-
ate the individual RCTs to assess the overall quality of the
meta-analysis [4,9].
Table 2: Checklist for the surgeon to critically appraise a meta-analysis
Has a research question/hypothesis been formulated a priori (before starting the meta-analysis)?
Is the research question FINER[20] (Feasible, Interesting, Novel, Ethical, and Relevant)?
Is the meta-analysis based on a written protocol that clearly outlines research question, primary and secondary outcomes, and inclusion and 
exclusion criteria?
Has a thorough literature search been performed? Have different search engines (PubMed, Embase, Cochrane library, etc.) been used to identify 
relevant literature?
Did the authors look for unpublished data, for negative studies, and for publications in non-English languages to minimize retrieval, language, and 
publication bias?
Was a strategy to exclude individual studies clearly outlined in the publication?
Did two investigators independently perform the quality assessment of the individual studies?
Were sensitivity analyses performed?Patient Safety in Surgery 2009, 3:16 http://www.pssjournal.com/content/3/1/16
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Publication bias
There is a well-known phenomenon, extensively docu-
mented in the published literature, whereby positive trials
(studies that produce a statistically significant result) are
much more likely to be published than so-called negative
trials (studies producing no statistically significant associ-
ation), or trials that produce equivocal results [1,24].
There are a number of possible reasons for the existence of
such a bias, but although editorial bias in medical jour-
nals is often held as a culprit, there is some evidence to
suggest that the bias may also arise when investigators or
sponsors simply decide not to write and publish negative
results[25]. Regardless of its origin, however, publication
bias may lead to overestimating the effect of the interven-
tion being examined in the meta-analysis. Thus, in order
to ensure the reliability of a meta-analysis, one must sys-
tematically search for negative trials for inclusion.
A variety of methods are used to detect potential publica-
tion biases, including graphical depiction through the use
of funnel plots [1,26]. In summary, such plots are scatter
diagrams of the estimated treatment effects in the individ-
ual studies against the study size. Small studies will give
more variable estimates and hence greater scatter. When
completed, the plot should have a symmetrical appear-
ance like that of a triangle or inverted funnel. An asymme-
try in the funnel plot may reflect the possibility that
smaller studies were not published due to non-significant
findings, thus indicating publication bias. Funnel plots
are easy-to-use, practical tools and should be employed
systematically to detect and possibly prevent publication
bias [27].
Recent consensus statements by the World Health Organ-
ization (WHO) and the International Council of Medical
Journal Editors (ICMJE) [28] have led to requirements
that any RCT be registered with http://www.clinicaltri-
als.gov/  before commencing patient accrual; failing to do
so may render the study unable to be published by a large
and growing number of peer-reviewed journals and addi-
tional sanctions may apply to researchers who neglect to
register clinical trials. Although even the most finely-
honed searches may fail to reveal negative data that has
simply been "shelved" by investigators or sponsors, any
author attempting a meta-analysis should exhaust every
possible avenue for obtaining the most complete set of
data possible.
Retrieval bias and language bias are often considered as
two facets of publication bias and will be discussed below.
Retrieval bias
This bias refers to a potential distortion of the findings of
a meta-analysis due to the overlooking or exclusion of rel-
evant studies that merit inclusion in the meta-analysis.
Retrieval bias may be the result of suboptimal search of
electronic databases and failing to identify important
unpublished results. It is critically important to search a
variety of different databases [29]. Novice researchers
should be particularly attentive to carefully choosing
search terms. The appropriate use of Medical Search Head-
ers (MeSH) keywords and Boolean search strings can help
maximize the retrieval of relevant articles; in particular,
relatively inexperienced researchers may wish to experi-
ment with search tutorials, such as those offered by
PubMed, and refer to the growing body of literature
regarding the optimization of literature searches.
Language bias
Language bias is closely related with retrieval bias. It refers
to a potential distortion of the results of a meta-analysis
due to a failure to identify relevant study findings pub-
lished in languages other than English. If a methodologi-
cally sound meta-analysis is performed, the investigators
must systematically search for relevant studies outside of
the scientific English literature [30].
Heterogeneity
Because perioperative care and surgical techniques are not
necessarily uniform or easily standardized [9] meta-anal-
yses are consequently more difficult to perform on surgi-
cal interventions than in drug trials. Dealing with such
heterogeneity may be challenging: Not only is there a risk
of heterogeneity within the RCT, but this heterogeneity
may be amplified when combining different trials. There-
fore, if the heterogeneity among the various RCTs
included in a meta-analysis is high, the investigator risks
comparing apples and oranges. Although it may occur by
chance alone, heterogeneity in surgical trials is most often
associated with variation in technical ability among sur-
geons [9].
Well-designed and rigorously performed multi-center sur-
gical RCTs now typically contain some validation of
standardized surgical technique. For instance, standardi-
zation can be achieved through peer review of surgical
procedures. A good example of this is the COST trial,
which compared open and laparoscopic colectomies for
cancer [31]. Before the laparoscopic surgeons were
allowed to enroll patients into the trial, their surgical tech-
niques were submitted to peer review, thereby ensuring a
baseline standard. The peer review process diminishes the
risk of suboptimal technical skills acting as a potential
confounder and enhances homogeneity of surgical skills
among similar trials.
The extent of heterogeneity among various trials can be
determined through the application of the method of sen-
sitivity analysis. In this case, what is important is not
whether the subgroups remain statistically significant
with respect to the overall research question, but whether
any statistically significant differences exist among them.Patient Safety in Surgery 2009, 3:16 http://www.pssjournal.com/content/3/1/16
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Also, if homogeneity exists, then omitting a certain trial
from the analysis should not change the overall result.
Conversely, if heterogeneity is present, then omitting a
key trial may well change the pooled estimate. It follows
that the more similar the included RCTs are, the less the
degree of heterogeneity. If too much heterogeneity is
found among different RCTs in the area of interest, per-
forming a meta-analysis may not be feasible, and the
reporting of different studies in a systematic review may
be more appropriate.
Conclusion
Basic knowledge of the advantages and limitations of
meta-analyses is essential to the practicing surgeon.
Although meta-analyses are considered the highest level
of evidence and an essential part of medical research, the
clinician must be aware of their potential limitations,
either when conducting a meta-analysis or interpreting
the findings from one. Combining independent RCTs
using statistical techniques will increase the statistical
power in the context of the research question, but this will
not necessarily translate into a higher-confidence conclu-
sion if the individual studies that make up the meta-anal-
ysis are not themselves sufficiently well-designed and
conducted.
Competing interests
The authors declare that they have no competing interests.
JM is an employee of the Duke Clinical Research Institute
but was not compensated in any fashion for his work on
this manuscript.
Authors' contributions
NL carried out conception and design of the review and
drafted the manuscript. JM participated in its design and
coordination and helped to draft the manuscript. UG con-
ceived of the study, and participated in its design, coordi-
nation and supervision. All authors read and approved
the final manuscript.
References
1. Mahid SS, Hornung CA, Minor KS, Turina M, Galandiuk S: System-
atic reviews and meta-analysis for the surgeon scientist.  Br J
Surg 2006, 93(11):1315-1324.
2. L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical
research.  Ann Intern Med 1987, 107(2):224-233.
3. Chalmers I: The Cochrane collaboration: preparing, maintain-
ing, and disseminating systematic reviews of the effects of
health care.  Ann N Y Acad Sci 1993, 703:156-163. discussion 163-
155
4. Ridgeway P, Guller U: Interpreting study designs in surgical
research – a practical guide for surgeons and surgical resi-
dents.  Journal of the American College of Surgeons 2009,
208(4):634-645.
5. Herrle F, Guller U: Evidence-Based Surgery Series: Part 2:
Interpreting Meta-Analyses and Systematic Reviews in Sur-
gical Research – A Practical Guide for Surgeons and Surgical
Residents.  Zeitschrift fuer Herz- Thorax- und Gefaesschirurgie 2009 in
press.
6. Guller U, Oertli D: Sample size matters: a guide for surgeons.
World J Surg 2005, 29(5):601-605.
7. Guller U, DeLong ER: Interpreting statistics in medical litera-
ture: a vade mecum for surgeons.  J Am Coll Surg 2004,
198(3):441-458.
8. Guller U: Caveats in the interpretation of the surgical litera-
ture.  Br J Surg 2008, 95(5):541-546.
9. Guller U: Surgical outcomes research based on administra-
tive data: inferior or complementary to prospective rand-
omized clinical trials?  World J Surg 2006, 30(3):255-266.
10. Deeks JJ, Macaskill P, Irwig L: The performance of tests of publi-
cation bias and other sample size effects in systematic
reviews of diagnostic test accuracy was assessed.  J Clin Epide-
miol 2005, 58(9):882-893.
11. Sauerland S, Seiler CM: Role of systematic reviews and meta-
analysis in evidence-based medicine.  World J Surg 2005,
29(5):582-587.
12. Neugebauer E, Lefering R, McPeek B, Wood-Dauphinee S: System-
atically reviewing previous work.  In Surgical Research: Basic Prin-
ciples and Clinical Practice Edited by: Troidi H, McKneally M, Mulder D.
Berlin: Springer; 1998:341-355. 
13. Wilczynski NL, Haynes RB: Developing optimal search strate-
gies for detecting clinically sound prognostic studies in
MEDLINE: an analytic survey.  BMC Med 2004, 2:23.
14. Robinson KA, Dickersin K: Development of a highly sensitive
search strategy for the retrieval of reports of controlled tri-
als using PubMed.  Int J Epidemiol 2002, 31(1):150-153.
15. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J: How to
identify randomized controlled trials in MEDLINE: ten years
on.  J Med Libr Assoc 2006, 94(2):130-136.
16. Dickersin K, Scherer R, Lefebvre C: Identifying relevant studies
for systematic reviews.  BMJ 1994, 309(6964):1286-1291.
17. Hopewell S, Clarke M, Lefebvre C, Scherer R: Handsearching ver-
sus electronic searching to identify reports of randomized
trials.  Cochrane Database Syst Rev 2007:MR000001.
18. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF:
Improving the quality of reports of meta-analyses of ran-
domised controlled trials: the QUOROM statement. Quality
of Reporting of Meta-analyses.  Lancet 1999,
354(9193):1896-1900.
19. CONSORT Statement  CONSORT Transparent Reporting of Trials
[http://www.consort-statement.org]. 31st July 2007; accessed 1st May
2009
20. Hulley S, Cummings S, Browner W, Grady D, Newman T: Designing
clinical research: an epidemiologic approach.  2nd edition. Phil-
adelphia: Lippincott Williams & Wilkins; 2001. 
21. Lewis S, Clarke M: Forest plots: trying to see the wood and the
trees.  BMJ 2001, 322(7300):1479-1480.
22. Guller U: Meta-Analyses: Advantages and Caveats.  Swiss Knife
2008, 4:16-17.
23. Phillips B, Ball C, Badenoch D, Straus S, Haynes B, Dawes M: Oxford
Centre for Evidence-based Medicine Levels of Evidence (May
2001).  BJU International 2008, 102:920.
24. Dickersin K: The existence of publication bias and risk factors
for its occurrence.  JAMA 1990, 263(10):1385-1389.
25. Olson CM, Rennie D, Cook D, Dickersin K, Flanagin A, Hogan JW,
Zhu Q, Reiling J, Pace B: Publication bias in editorial decision
making.  JAMA 2002, 287(21):2825-2828.
26. Egger M, Smith GD: Misleading meta-analysis.  BMJ 1995,
311(7007):753-754.
27. Mayer EK, Bottle A, Rao C, Darzi AW, Athanasiou T: Funnel plots
and their emerging application in surgery.  Ann Surg 2009,
249(3):376-383.
28. Deangelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R,
Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC,
Weyden MB Van Der: Is this clinical trial fully registered? A
statement from the International Committee of Medical
Journal Editors.  JAMA 2005, 293(23):2927-2929.
29. Greenhalgh T: Papers that summarise other papers (system-
atic reviews and meta-analyses).  BMJ 1997,
315(7109):672-675.
30. Parnaby CN, MacDonald AJ, Jenkins JT: Sham feed or sham? A
meta-analysis of randomized clinical trials assessing the
effect of gum chewing on gut function after elective colorec-
tal surgery.  Int J Colorectal Dis 2009, 24(5):585-592.
31. A comparison of laparoscopically assisted and open colec-
tomy for colon cancer.  N Engl J Med 2004, 350(20):2050-2059.